In February 2023, the Government published its first ever strategy for MedTech, outlining our priorities for improving the adoption and spread of safe, effective and innovative medical technologies across the National Health Service.<\/p>
As part of this effort, we are implementing solutions to streamline the innovation adoption pathway. We are focusing on clarifying signals to industry on what innovation the NHS needs, reforming regulation, providing product assessments based on real world evidence, and improving procurement processes.<\/p>
We recently launched the Innovative Devices Access Pathway pilot in September 2023. The pilot will test a pre-regulatory, access pathway for eight pilot technologies that meet a clinical unmet need in the NHS. This accelerated pathway will support the adoption of transformative technologies into the NHS and to patients.<\/p>
The Government is investing £30 million in the Health Tech Adoption and Acceleration Fund. Funding has been disseminated to all 42 integrated care systems to invest in proven technology that will help cut waiting lists, speed up diagnosis and deliver new and improved ways to treat patients.<\/p>
The Department has partnered with the National Institute for Health and Care Excellence to develop and pilot a process for evaluations that compare similar MedTech products in use across the NHS. These evaluations will improve NHS decision makers ability to identify which products offer value for money and are worth adopting more widely.<\/p>
The Medicines and Healthcare products Regulatory Agency is updating the medical device regulatory framework. The new framework is designed to protect patient safety, support innovation within the United Kingdom\u2019s life sciences sector and improve access to innovative medical devices.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-01-22T11:35:47.79Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-01-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the (a) adoption and (b) spread of medical technologies across the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"} , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"} ], "uin" : "10124"} , {"_about" : "http://data.parliament.uk/resources/1669252", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1669252/answer", "answerText" : {"_value" : "
A key criterion is clear, meaningful metrics that directly align to the core priorities of the Strategy. We are working with system partners, industry and patient groups and other key stakeholders to develop meaningful metrics for each initiative and for the overall robust evaluation of the strategy.<\/p>
Our previous answer, which you reference in your question, outlined the range of different initiatives we are progressing. Each initiative is at a different stage of progress and will work up individual, appropriate criteria with their key delivery partners. These will be reported to programme governance structures as they become available.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2023-11-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-20T17:07:05.947Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4807", "label" : {"_value" : "Biography information for Mark Eastwood"} } , "tablingMemberConstituency" : {"_value" : "Dewsbury"} , "tablingMemberPrinted" : [{"_value" : "Mark Eastwood"} ], "uin" : "1400"} , {"_about" : "http://data.parliament.uk/resources/1666862", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1666862/answer", "answerText" : {"_value" : "
It has not proved possible to respond to the hon. Member in the time available before Prorogation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-10-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-10-26T08:59:38.98Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-10-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Innovation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4807", "label" : {"_value" : "Biography information for Mark Eastwood"} } , "tablingMemberConstituency" : {"_value" : "Dewsbury"} , "tablingMemberPrinted" : [{"_value" : "Mark Eastwood"} ], "uin" : "204055"} , {"_about" : "http://data.parliament.uk/resources/1661404", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1661404/answer", "answerText" : {"_value" : "
The Department\u2019s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.<\/p>
The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.<\/p>
The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:<\/p>
https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap<\/a><\/p> The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.<\/p> The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.<\/p> The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.<\/p> The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:<\/p> https://innovation.nhs.uk/<\/a><\/p> We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-10-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "200120"}
, {"_value" : "200122"}
, {"_value" : "200123"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-10-16T13:22:56.323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-09-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Treatments: Innovation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the adoption of innovative medical technologies by the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4807", "label" : {"_value" : "Biography information for Mark Eastwood"}
}
, "tablingMemberConstituency" : {"_value" : "Dewsbury"}
, "tablingMemberPrinted" : [{"_value" : "Mark Eastwood"}
], "uin" : "200121"}
, {"_about" : "http://data.parliament.uk/resources/1661405", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1661405/answer", "answerText" : {"_value" : " The Department\u2019s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.<\/p> The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.<\/p> The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:<\/p> https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap<\/a><\/p> The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.<\/p> The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.<\/p> The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.<\/p> The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:<\/p> https://innovation.nhs.uk/<\/a><\/p> We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-10-16", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "200120"}
, {"_value" : "200121"}
, {"_value" : "200123"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-10-16T13:22:56.37Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-09-18", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Treatments: Innovation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to innovative medical technologies through the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4807", "label" : {"_value" : "Biography information for Mark Eastwood"}
}
, "tablingMemberConstituency" : {"_value" : "Dewsbury"}
, "tablingMemberPrinted" : [{"_value" : "Mark Eastwood"}
], "uin" : "200122"}
, {"_about" : "http://data.parliament.uk/resources/1661406", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1661406/answer", "answerText" : {"_value" : " The Department\u2019s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.<\/p> The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.<\/p> The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:<\/p>